HBVAXPRO 40
HBVAXPRO 40 is a medicine authorised by Swissmedic under authorisation number 545. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 April 1988 and the authorisation is valid without a time limit. ATC code J07BC01 places the medicine in the group Vaccines.
| Authorisation number | 545 |
|---|---|
| Name | HBVAXPRO 40 |
| Full name | HBVAXPRO 40, Injektionssuspension |
| Authorisation holder | MSD Merck Sharp & Dohme AG |
| Medicinal product code | Vaccines |
| Dispensing category | B · Prescription only |
| ATC code | J07BC01 |
| First authorisation | 18 April 1988 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | HBVAXPRO 40, Injektionssuspension | B | 18 April 1988 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | J07BC01 | 08.08. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is HBVAXPRO 40 authorised in Switzerland?
Yes. HBVAXPRO 40 is authorised by Swissmedic under authorisation number 545, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does HBVAXPRO 40 have?
HBVAXPRO 40 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of HBVAXPRO 40?
The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.